IFNG and cancer: As sentinels in tumor surveillance and potent effectors of antitumor response, γδ T cells have become attractive candidates for alternative cancer immunotherapy strategies, and amino-bisphosphonate drugs, such as zoledronate, are being exploited to trigger their ex vivo or in vivo activation, expansion, and IFN-γ production [38].